FLASH Radiotherapy: Biological Mechanisms and Potential for Reducing Radiation-Induced Organ Toxicity
PDF (angielski)

Słowa kluczowe

FLASH radiotherapy
ultra-high dose rate
organ toxicity

Jak cytować

Cichy, Julia, i Igor Piotrowski. 2026. „FLASH Radiotherapy: Biological Mechanisms and Potential for Reducing Radiation-Induced Organ Toxicity”. Zeszyty Naukowe Wielkopolskiego Centrum Onkologii 23 (4). https://doi.org/10.21641/los.2026.23.4.312.

Abstrakt

Radiotherapy (RT) remains a cornerstone of oncological management, indicated for over half of all cancer patients. Although technological iterations — intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) — have refined spatial precision relative to conventional two-dimensional approaches, radiation-induced normal tissue toxicity persists as a critical dose-limiting constraint.

The radiobiological mechanisms of ionising radiation encompass direct macromolecular DNA damage and indirect oxidative stress propagated by reactive oxygen species, with cellular outcomes heavily modulated by the dose delivery rate. Consequently, ultra-high dose-rate FLASH-RT has emerged as a novel paradigm, executing therapeutic delivery within millisecond intervals at dose rates exceeding 40 Gy/s.

Preclinical and nascent clinical data demonstrate that FLASH irradiation maintains robust tumouricidal efficacy while substantially attenuating normal tissue sequelae. This differential response is hypothesised to arise from transient microenvironmental oxygen depletion, altered reactive oxygen species kinetics, differential DNA damage repair pathways, and distinct immunomodulatory interactions. While the precise molecular orchestration requires further elucidation, FLASH-RT possesses the potential to optimise the therapeutic index. Systematic experimental and clinical validation remains imperative to standardise delivery parameters and integrate this modality into routine clinical oncology.

PDF (angielski)

Bibliografia

1. Sung H, Filho AM, Laversanne M, et al (2026) Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin 76:e70090. https://doi.org/10.3322/caac.70090

2. Chen S, Cao Z, Prettner K, et al (2023) Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncol 9:465–472. https://doi.org/10.1001/jamaoncol.2022.7826

3. Maani EV, Maani CV (2025) Radiation Therapy. In: StatPearls. StatPearls Publishing, Treasure Island (FL)

4. Guadagnolo BA, Liao K-P, Elting L, et al (2013) Use of Radiation Therapy in the Last 30 Days of Life Among a Large Population-Based Cohort of Elderly Patients in the United States. J Clin Oncol 31:80–87. https://doi.org/10.1200/JCO.2012.45.0585

5. World Health Organization (2021) Technical specifications of radiotherapy equipment for cancer treatment

6. Krzakowski M, Jassem J, Antczak A, et al (2022) Thoracic neoplasms. Oncol Clin Pract 18:1–39. https://doi.org/10.5603/OCP.2021.0022

7. Chargari C, Deutsch E, Blanchard P, et al (2019) Brachytherapy: An overview for clinicians. CA Cancer J Clin 69:386–401. https://doi.org/10.3322/caac.21578

8. Pańczyszyn M, Bąk O, Kijeska W, et al (2022) Przegląd technik radioterapeutycznych wykorzystywanych w napromienianiu nowotworu odbytnicy. Lett Oncol Sci 19:. https://doi.org/10.21641/los.2022.19.1.227

9. Bucci MK, Bevan A, Roach M (2005) Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin 55:117–134. https://doi.org/10.3322/canjclin.55.2.117

10. Ślosarek K, Składowski K, Rembielak A, et al (2001) Intensity Modulated Radiation Therapy (IMRT) - description of the technique. Nowotw J Oncol 51:614–614

11. Held KD, McNamara AL, Daartz J, et al (2024) Dose Rate Effects from the 1950s through to the Era of FLASH. Radiat Res 202:161–176. https://doi.org/10.1667/RADE-24-00024.1

12. Durante M, Bräuer-Krisch E, Hill M (2018) Faster and safer? FLASH ultra-high dose rate in radiotherapy. Br J Radiol 91:20170628. https://doi.org/10.1259/bjr.20170628

13. Wei W, Ren Y, Lan J, et al (2026) Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets. Mol Biomed 7:3. https://doi.org/10.1186/s43556-025-00358-4

14. Alizadeh E, Orlando TM, Sanche L (2015) Biomolecular damage induced by ionizing radiation: the direct and indirect effects of low-energy electrons on DNA. Annu Rev Phys Chem 66:379–398. https://doi.org/10.1146/annurev-physchem-040513-103605

15. Pouget J-P Basics of radiobiology. In: Basics of radiobiology. pp 30–51

16. Repetto M, Semprine J, Boveris A (2012) Lipid Peroxidation: Chemical Mechanism, Biological Implications and Analytical Determination. In: Lipid Peroxidation. IntechOpen

17. Hughes JR, Parsons JL (2020) FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy. Int J Mol Sci 21:6492. https://doi.org/10.3390/ijms21186492

18. Zeman E (2012) Clinical Radiation Oncology, Third Edition

19. Malicki J, Ślosarek K Planowanie leczenia i dozymetria w radioterapii

20. Yu Z, Xu C, Song B, et al (2023) Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances. J Transl Med 21:708. https://doi.org/10.1186/s12967-023-04554-0

21. Majeed H, Gupta V (2025) Adverse Effects of Radiation Therapy. In: StatPearls. StatPearls Publishing, Treasure Island (FL)

22. Lin ZC, Bennett MH, Hawkins GC, et al (2023) Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev 8:CD005005. https://doi.org/10.1002/14651858.CD005005.pub5

23. Afrin KT, Ahmad S (2022) Is IMRT or VMAT superior or inferior to 3D conformal therapy in the treatment of lung cancer? A brief literature review. J Radiother Pract 21:416–420. https://doi.org/10.1017/S146039692100008X

24. Zhao W, Shen L, Islam MT, et al (2021) Artificial intelligence in image-guided radiotherapy: a review of treatment target localization. Quant Imaging Med Surg 11:4881–4894. https://doi.org/10.21037/qims-21-199

25. Favaudon V, Caplier L, Monceau V, et al (2014) Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med 6:245ra93. https://doi.org/10.1126/scitranslmed.3008973

26. Thomlinson RH, Gray LH (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9:539–549. https://doi.org/10.1038/bjc.1955.55

27. Spitz DR, Buettner GR, Petronek MS, et al (2019) An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses. Radiother Oncol J Eur Soc Ther Radiol Oncol 139:23–27. https://doi.org/10.1016/j.radonc.2019.03.028

28. Okoro C, Schüler E, Taniguchi C (2022) The Therapeutic Potential of FLASH-RT for Pancreatic Cancer. Cancers 14:1167. https://doi.org/10.3390/cancers14051167

29. Abolfath R, Grosshans D, Mohan R (2020) Oxygen depletion in FLASH ultra-high-dose-rate radiotherapy: A molecular dynamics simulation. Med Phys 47:6551–6561. https://doi.org/10.1002/mp.14548

30. Lee SE, Sheen H, Kim Y, et al (2026) Localized normal tissue-sparing effects of proton FLASH radiotherapy in a preclinical lung irradiation model. Br J Radiol 99:459–467. https://doi.org/10.1093/bjr/tqag015

31. Almeida A, Togno M, Ballesteros-Zebadua P, et al (2024) Dosimetric and biologic intercomparison between electron and proton FLASH beams. Radiother Oncol J Eur Soc Ther Radiol Oncol 190:109953. https://doi.org/10.1016/j.radonc.2023.109953

32. Beyreuther E, Brand M, Hans S, et al (2019) Feasibility of proton FLASH effect tested by zebrafish embryo irradiation. Radiother Oncol 139:46–50. https://doi.org/10.1016/j.radonc.2019.06.024

33. Vozenin M-C, De Fornel P, Petersson K, et al (2019) The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients. Clin Cancer Res 25:35–42. https://doi.org/10.1158/1078-0432.CCR-17-3375

34. Bourhis J, Sozzi WJ, Jorge PG, et al (2019) Treatment of a first patient with FLASH-radiotherapy. Radiother Oncol J Eur Soc Ther Radiol Oncol 139:18–22. https://doi.org/10.1016/j.radonc.2019.06.019

35. Mascia AE, Daugherty EC, Zhang Y, et al (2023) Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial. JAMA Oncol 9:62–69. https://doi.org/10.1001/jamaoncol.2022.5843

36. Daugherty EC, Zhang Y, Xiao Z, et al (2026) FAST-02: Results from the second in-human prospective evaluation of single-fraction proton FLASH for symptomatic thoracic bone metastases. Radiother Oncol J Eur Soc Ther Radiol Oncol 222:111671. https://doi.org/10.1016/j.radonc.2026.111671

37. Kinj R, Schiappacasse L, Grilj V, et al (2026) A phase I dose escalation of FLASH radiotherapy in patients with cutaneous metastases from melanoma: The IMPulse trial. Radiother Oncol J Eur Soc Ther Radiol Oncol 221:111414. https://doi.org/10.1016/j.radonc.2026.111414

Creative Commons License

Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Bez utworów zależnych 4.0 Międzynarodowe.

Prawa autorskie (c) 2026 Zeszyty Naukowe WCO

Downloads

Download data is not yet available.